Increased allopregnanolone levels in the fetal sheep brain following umbilical cord occlusion.
Allopregnanolone (AP) is a potent modulator of the GABAA receptor. Brain AP concentrations increase in response to stress, which is thought to provide neuroprotection by reducing excitation in the adult brain. Umbilical cord occlusion (UCO) causes hypoxia and asphyxia in the fetus, which are major risk factors associated with poor neurological outcome for the neonate, and may lead to adverse sequelae such as cerebral palsy. The aims of this study were as follows: (i) to determine the effect of 10 min UCO on AP concentrations in the extracellular fluid of the fetal brain using microdialysis, and (ii) to compare the content of the steroidogenic enzymes P450scc and 5alpha-reductase type II (5alphaRII) with brain and CSF neurosteroid concentrations. UCO caused fetal asphyxia, hypertension, bradycardia and respiratory acidosis, which returned to normal levels after 1-2 h. AP concentrations in dialysate samples from probes implanted in grey and white matter of the parietal cortex were significantly increased 1 h after UCO from control levels of 10.4 +/- 0.4 and 12.4 +/- 0.3 to 26.0 +/- 5.1 and 27.6 +/- 6.4 nmol l(-1), respectively (P < 0.05), before returning to pre-occlusion levels by 3-4 h after UCO. When fetal brains were collected 1 h after a 10 min UCO, the relative increases of AP and pregnenolone content in the parietal cortex were similar to the increase observed in the extracellular (dialysate) fluid. AP, but not pregnenolone, was increased in CSF at this time. P450scc and 5alphaRII enzyme expression was significantly increased in the cerebral cortex in the UCO fetuses compared to control fetuses. These results suggest that the fetal brain is capable of transiently increasing neurosteroid production in response to asphyxia. The action of the increased neurosteroid content at GABAA receptors may serve to diminish the increased excitation due to excitotoxic amino acid release, and provide short-term protection to brain cells during such stress.
Fetal and Neonatal Research Group, Department of Physiology, Monash University, Clayton, Victoria 3800, Australia.
Phuong N
PN
Nguyen
Edwin B
EB
Yan
Margie
M
Castillo-Melendez
David W
DW
Walker
Jonathan J
JJ
Hirst
D000818:Animals; D001794:Blood Pressure; D001921:Brain / Q000196:embryology*; D042944:Cholestenone 5 alpha-Reductase / Q000378:metabolism; D002786:Cholesterol Side-Chain Cleavage Enzyme / Q000378:metabolism; D003250:Constriction; D045604:Extracellular Fluid / Q000378:metabolism; D005312:Fetal Blood; D005333:Fetus / Q000378:metabolism; D005740:Gases / Q000097:blood; D006340:Heart Rate, Fetal; D006863:Hydrogen-Ion Concentration; D007527:Isoenzymes / Q000378:metabolism; D017551:Microdialysis; D009994:Osmolar Concentration; D011280:Pregnanolone / Q000097:blood / Q000378:metabolism*; D011284:Pregnenolone / Q000097:blood / Q000378:metabolism; D012756:Sheep; D014470:Umbilical Cord / Q000502:physiology*
D005740:Gases; D007527:Isoenzymes; D011284:Pregnenolone; D011280:Pregnanolone; D002786:Cholesterol Side-Chain Cleavage Enzyme; D042944:Cholestenone 5 alpha-Reductase